Chinese firm Insilico to test AI-developed drug

Published March 8, 2021
Insilico Medicine said that its chemical compound candidate is likely to enter into clinical trials by the end of this year. — AFP/File
Insilico Medicine said that its chemical compound candidate is likely to enter into clinical trials by the end of this year. — AFP/File

Insilico Medicine, a Chinese investors-backed company that uses artificial intelligence to develop new drugs, said that its chemical compound candidate is likely to enter into clinical trials by the end of this year, according to its top executives.

"We expect our chemical compound candidate to start its first clinic trial by the end of the end before the second and third trials," said Ren Feng, chief science officer at Insilico Medicine.

"(Once finished), it will be the first time that the world uses AI to find new targets, discover new compounds, and makes into the clinical period, which will be a milestone," Ren said.

The company announced recently that it has found a new therapeutic target and potential therapy candidate for idiopathic pulmonary fibrosis, or IPF, through AI technologies. It said that the potential therapy has been validated in preclinical tests in human tissue and animal models of IPF.

"This is the first case where AI identified a novel target and designed a preclinical candidate for a very broad disease indication…and we need to have many enabling AI technologies that help us understand and manipulate human biology in other chronic diseases," said Alex Zhavoronkov, founder and CEO of Insilico Medicine.

According to him, the entire research and development process only takes 18 months and costs only one-tenth of a similar project.

Industry insiders said the development of a new drug is a complex and resource-consuming process, which usually costs pharmaceutical companies an average of $2.6 billion and up to 10 years of research and development.

"Customers are beginning to pay more attention to healthcare and they are more aware of the use of AI after the Covid-19 pandemic. AI is set to play a greater role in driving the medical and healthcare industry," said Kaifu-Lee, chairman and CEO of venture capital firm Sinovation Ventures, which invested into Insilico Medicine.

"The bottom layer of AI is the digital evolution. In whatever field that can become digital, it is possible to use data science and AI to help such area to increase its value," he said.

Liang Yingyu, managing partner of Qiming Venture Partners, said that AI image recognition was the first large-scale application of AI in the medical field, and then expanded drug research and development.

"But there are still many areas where AI is not engaged into. The prospect of AI medical industry enjoys broad prospect," she noted.

This article originally appeared on China Daily and has been reproduced with permission.

Opinion

Diverging paths
Updated 15 Apr 2021

Diverging paths

It seems that Imran Khan is feeling the pain of the adjustment that he has had to undertake.
Judging the judges
15 Apr 2021

Judging the judges

In the end, like Joan of Arc, they were made to pay with their blood.
People to people
Updated 15 Apr 2021

People to people

By facilitating access, the governments of India and Pakistan can start to build trust and understanding between the two publics.
Hostage to extremism
Updated 14 Apr 2021

Hostage to extremism

Once again, the TLP has succeeded in bringing the administration to its knees.

Editorial

Afghanistan exit
Updated 15 Apr 2021

Afghanistan exit

Afghanistan has suffered for decades as powerful local players have refused to compromise and have insisted on hogging power.
15 Apr 2021

New census

EARLIER this week, the Council of Common Interests approved the controversial National Population and Housing ...
15 Apr 2021

With no place to go

No matter where one looks, one can’t escape the heartrending sight of scores of children of all ages begging, ...
TLP protests
Updated 14 Apr 2021

TLP protests

For the good of the country, and its image as a nation where extremism has no place, such groups must be strictly reined in.
14 Apr 2021

PPP’s formal exit

THE PPP’s formal resignation from all offices of the PDM comes as no surprise after weeks of tension and public...
14 Apr 2021

Natanz attack

AS the P5+1 and Iran try to breathe life back into the JCPOA, as the nuclear deal is officially known, it appears...